The present application generally relates electrodes for delivering energy or stimulus to tissue or structure of the body. More specifically, the application relates to electrode manufacturing processes.
Co-pending U.S. application Ser. No. 13/547,031 entitled System and Method for Acute Neuromodulation, filed Jul. 11, 2012 (Attorney Docket: IAC-1260; the “'031 application”), filed by an entity engaged in research with the owner of the present application, describes a system which may be used for hemodynamic control in the acute hospital care setting, by transvascularly directing therapeutic stimulus to parasympathetic nerves and/or sympathetic cardiac nerves using electrodes positioned in the superior vena cava (SVC). In disclosed embodiments, delivery of the parasympathetic and sympathetic therapy decreases the patient's heart rate (through the delivery of therapy to the parasympathetic nerves) and elevates or maintains the blood pressure (through the delivery of therapy to the cardiac sympathetic nerves) of the patient in treatment of heart failure.
Co-pending U.S. application Ser. No. 14/642,699 (the '699), filed Mar. 9, 2015 and U.S. Ser. No. 14/801,560 (the '560), filed Jul. 16, 2015, each incorporated by reference, describe transvascularly directing therapeutic stimulus to parasympathetic and/or sympathetic cardiac nerves using electrodes positioned in the SVC, right brachiocephalic vein, and/or left brachiocephalic vein and/or other sites. As with the system disclosed in the '031, the methods disclosed in these applications can decrease the patient's heart rate (through the delivery of therapy to the parasympathetic nerves) and elevate or maintain the blood pressure (through the delivery of therapy to the cardiac sympathetic nerves) of the patient in treatment of heart failure.
The '699 and '560 applications describe one form of catheter device that may be used to perform transvascular neuromodulation. In particular, these applications shows a support or electrode carrying member 10 of the type shown in
Co-pending and commonly owned U.S. application Ser. No. ______ (Attorney Ref: NTK2-2010), filed Dec. 12, 2019 and incorporated herein by reference, describes electrode support assemblies in which flexible circuits (having electrodes and/or other components on them) may be mounted to an electrode support. Referring to
Concepts described in the present application may be used to create an electrode surface, which may on a flex circuit, capable of achieving the current densities needed to carry out the therapy performed in the referenced applications, and for the durations at which therapy could be applied in the acute setting (e.g. up to 96 hours).
This application describes processes that may be used to create an electrode surface capable of achieving the current densities needed to carry out the therapy performed in the referenced applications, and for the durations at which therapy could be applied in the acute setting (e.g. up to 96 hours). These processes make use of a laser skiving process or other suitable process to enhance the topography of the electrodes, thus making the electrodes cable of achieving higher charge capacities, and they additionally apply a high specific surface area materials (e.g. IrOx or PEDOT) to the electrode surface to further increase the effective surface area and thus the storage capacity of the electrode surface.
In accordance with a first example of an electrode manufacturing method 300 illustrated in
A second example of a manufacturing process 400 is shown in
The processes described above result in creation of a flexible circuit having one or more electrodes, each of which possesses an electrode surface particularly suitable for transvascular stimulation of nerve targets in therapies such as those described in the referenced applications, which require high charge densities over extended time periods (e.g. up to 96 hours). The flexible circuits may be mounted to electrode carrying members such as the strut arrangements described above with respect to
All applications and patents referred to herein, including for purposes of priority, and incorporated herein by reference.
This application claims the benefit of U.S. Provisional Application No. 62/772,352, filed Dec. 12, 2019.
Number | Date | Country | |
---|---|---|---|
62778352 | Dec 2018 | US |